Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858
出版年份 2017 全文链接
标题
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858
作者
关键词
-
出版物
LEUKEMIA
Volume 31, Issue 10, Pages 2172-2180
出版商
Springer Nature
发表日期
2017-01-18
DOI
10.1038/leu.2017.21
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts
- (2016) S. Vasu et al. BLOOD
- The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
- (2016) A. A. Basiorka et al. BLOOD
- Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia
- (2015) R. Somasundaram et al. BLOOD
- Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
- (2014) Robert K Hills et al. LANCET ONCOLOGY
- Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
- (2013) J. M. Rowe et al. BLOOD
- Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
- (2013) Moshe Sade-Feldman et al. IMMUNITY
- Induction of myelodysplasia by myeloid-derived suppressor cells
- (2013) Xianghong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
- (2013) Tamar Kapanadze et al. JOURNAL OF HEPATOLOGY
- Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis
- (2012) Marc H. G. P. Raaijmakers INTERNATIONAL JOURNAL OF HEMATOLOGY
- Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5q
- (2011) Daniel T. Starczynowski et al. CELL CYCLE
- Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions
- (2011) Junmin Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
- (2011) Sigurdur Y. Kristinsson et al. JOURNAL OF CLINICAL ONCOLOGY
- Myelodysplastic syndromes and bone marrow microenvironment
- (2011) Matteo Giovanni Della Porta LEUKEMIA RESEARCH
- Innate Immune Signaling in the Myelodysplastic Syndromes
- (2010) Daniel T. Starczynowski et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
- (2010) Marc H. G. P. Raaijmakers et al. NATURE
- The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
- (2009) Jan M. Ehrchen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
- (2009) S. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia
- (2008) X. Chen et al. BLOOD
- Myelodysplastic syndromes
- (2008) S. D. Nimer BLOOD
- Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
- (2008) Derek L. Stirewalt et al. BRITISH JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started